Startseite Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative

  • Patrick M. Bossuyt , Johannes B. Reitsma , David E. Bruns , Constantine A. Gatsonis , Paul P. Glasziou , Les M. Irwig , Jeroen G. Lijmer , Drummond Rennie David Moher und Henrica C.W. de Vet
Veröffentlicht/Copyright: 1. Juni 2005
Veröffentlichen auch Sie bei De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 41 Heft 1

Abstract

Objective – To improve the accuracy and completeness of reporting of studies of diagnostic accuracy, to allow readers to assess the potential for bias in the study and to evaluate its generalisability.

Methods – The Standards for Reporting of Diagnostic Accuracy (STARD) steering committee searched the literature to identify publications on the appropriate conduct and reporting of diagnostic studies and extracted potential items into an extensive list. Researchers, editors, and members of professional organisations shortened this list during a two-day consensus meeting with the goal of developing a checklist and a generic flow diagram for studies of diagnostic accuracy.

Results – The search for published guidelines regarding diagnostic research yielded 33 previously published checklists, from which we extracted a list of 75 potential items. At the consensus meeting, participants shortened the list to 25 items, using evidence on bias whenever available. A prototypical flow diagram provides information about the method of patient recruitment, the order of test execution and the numbers of patients undergoing the test under evaluation, the reference standard or both.

Conclusions – Evaluation of research depends on complete and accurate reporting. If medical journals adopt the checklist and the flow diagram, the quality of reporting of studies of diagnostic accuracy should improve to the advantage of clinicians, researchers, reviewers, journals, and the public.

:
Published Online: 2005-06-01
Published in Print: 2003-01-27

Copyright © 2003 by Walter de Gruyter GmbH & Co. KG

Artikel in diesem Heft

  1. Evidence-Based Laboratory Medicine: Addressing Bias, Generalisability and Applicability in Studies on Diagnostic Accuracy. The STARD Initiative
  2. Semen Polymorphonuclear Neutrophil Leukocyte Elastase as a Diagnostic and Prognostic Marker of Genital Tract Inflammation – A Review
  3. Total Oxyradical Scavenging Capacity toward Different Reactive Oxygen Species in Seminal Plasma and Sperm Cells
  4. Identification of New Polymorphisms in the CACNA1S Gene
  5. 3-Nitrotyrosine in Atherosclerotic Blood Vessels
  6. Molecular Diagnosis of Cystic Fibrosis: Comparison of Four Analytical Procedures
  7. Assessment of Intestinal Permeability: Enzymatic Determination of Urinary Mannitol, Raffinose, Sucrose and Lactose on Hitachi Analyzer
  8. Effects of Calcium Carbonate, Magnesium Oxide and Sodium Citrate Bicarbonate Health Supplements on the Urinary Risk Factors for Kidney Stone Formation
  9. Glycerol Metabolism and the Determination of Triglycerides –Clinical, Biochemical and Molecular Findings in Six Subjects
  10. Plasma Lipid Composition and LDL Oxidation
  11. Modified Method to Measure Nasal Potential Difference
  12. Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative
  13. Novel and Traditional Biomarkers of Bone Turnover in Postmenopausal Women
  14. Urinary Plasma Protein Patterns in Acute Prostatitis
  15. Adequate Sampling in Cryoglobulinaemia: Recommended Warmly
  16. A New Modification of the Chiron ACS Assay for Total Prostate-Specific Antigen Achieves Equimolar Response Characteristics and Improves the Detection of Prostate Cancer
  17. Technical Performance and Diagnostic Utility of the New Elecsys® Neuron-Specific Enolase Enzyme Immunoassay
  18. Measurements of Complement Factor H-Related Protein (BTA-TRAK™ Assay) and Nuclear Matrix Protein (NMP22 Assay) – Useful Diagnostic Tools in the Diagnosis of Urinary Bladder Cancer?
  19. Erratum: The 18th International Congress of Clinical Chemistry and Laboratory Medicine. Special Supplement Abstracts Issue 2002
  20. Meetings and Awards
Heruntergeladen am 29.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2003.012/html
Button zum nach oben scrollen